SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remed. reports Profit after tax of Rs 23.37 Mln, in the June 2021 quarter

13 Jul 2021 Evaluate
A decent increase of about 41.56% in the sales to Rs. 126.33 millions was observed for the quarter ended June 2021. The sales figure stood at Rs. 89.24 millions during the year-ago period.Good  Net Profit growth of 41.64% reported above the corresponding previous quarter figure of Rs. 16.50 millions to Rs. 23.37 millioins.Operating profit for the quarter ended June 2021 rose to 41.63 millions as compared to 26.15 millions of corresponding quarter ended June 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202106 202006 % Var 202106 202006 % Var 202103 202003 % Var
Sales 126.33 89.24 41.56 126.33 89.24 41.56 490.82 584.26 -15.99
Other Income 11.08 9.38 18.12 11.08 9.38 18.12 20.95 41.78 -49.86
PBIDT 41.63 26.15 59.20 41.63 26.15 59.20 157.42 151.26 4.07
Interest 0.70 0.23 204.35 0.70 0.23 204.35 0.68 1.41 -51.77
PBDT 40.93 25.92 57.91 40.93 25.92 57.91 156.74 149.85 4.60
Depreciation 8.15 5.52 47.64 8.15 5.52 47.64 27.25 22.41 21.60
PBT 32.78 20.40 60.69 32.78 20.40 60.69 129.49 127.44 1.61
TAX 9.41 3.90 141.28 9.41 3.90 141.28 31.96 31.20 2.44
Deferred Tax -0.03 0.12 -125.00 -0.03 0.12 -125.00 -0.36 -0.56 -35.71
PAT 23.37 16.50 41.64 23.37 16.50 41.64 97.53 96.24 1.34
Equity 100.06 89.71 11.54 100.06 89.71 11.54 100.06 89.71 11.54
PBIDTM(%) 32.95 29.30 12.46 32.95 29.30 12.46 32.07 25.89 23.89

Shree Ganesh Remed. Share Price

514.05 -7.70 (-1.48%)
24-Apr-2026 12:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.65
Dr. Reddys Lab 1319.60
Cipla 1288.40
Zydus Lifesciences 931.10
Lupin 2269.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×